RUNX1 and Inherited Hematologic Malignancies Consortium

This list of experts is available to both patients (please call for an appointment) and medical professionals for consultation. Select any red marker on the map to view a clinician's details; click their name within the popup to access their full bio and contact information.

 

Mission Statement

To define the prevalence and phenotypic spectrum of inherited platelet disorders with predisposition to hematologic malignancies, and to determine mechanisms and pathways influencing bleeding risk and subsequent progression to malignancies, with a goal of developing prevention and treatment strategies for patients.

If you are interested in joining this consortium, please click here to complete and submit the form.

European Hematology Association Scientific Working Group on
Genetic Predisposition in Hematological Cancer

Subcommittee of Familial Platelet Disorders and Cancer Predisposition

 

If you are a clinician interested in contributing your expertise to this effort, please fill out and submit the form below and an RRP team member will contact you soon. Thank you!

Ongoing Clinical Trials

“Phase Ib Study of Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency”